ArticleAnesthesia and pain medicine2025
Treatment of severe pain in a patient with a cervical spinal cord injury at C5-7 level using an intrathecal targeted drug delivery system - A case report.
Article in Anesthesia and pain medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights.Frontiers in neuroscience · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPatients with cervical spinal cord injury (SCI) can experience pain refractory to aggressive multimodal therapies. Here, we report the use of an intrathecal targeted drug delivery (ITDD) system to treat severe pain in patients with cervical SCI. CASE: A 64-year-old male patient underwent spinal cord stimulation (SCS) for severe cervical SCI. We proceeded with the ITDD system, placing the catheter tip at the C6 level. After placement of the ITDD system, the patient was monitored for regular refills of morphine sulfate in the drug delivery reservoir every 6 months. We reduced the oral morphine equivalent dose from nearly 333.8 mg/day to 133.8 mg/day.
conclusionsThe ITDD system may be a useful treatment option for patients with cervical SCI who have failed conventional treatments and do not show improvement with SCS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.